Ghrelin O-acyltransferase (GOAT) enzyme is overexpressed in prostate cancer, and its levels are associated with patient's metabolic status: Potential value as a non-invasive biomarker

Daniel Hormaechea‐Agulla(Baylor College of Medicine), Raúl M. Luque(Instituto de Salud Carlos III), Enrique Gómez‐Gómez(Instituto Maimónides de Investigación Biomédica de Córdoba), Rosa Ortega‐Salas(Instituto Maimónides de Investigación Biomédica de Córdoba), Rafael Sánchez‐Sánchez(Instituto Maimónides de Investigación Biomédica de Córdoba), Manuel D. Gahete(Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition), María M. Moreno(Instituto Maimónides de Investigación Biomédica de Córdoba), Fernando L‐López(Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition), José López‐Miranda(Instituto de Salud Carlos III), Sergio Pedraza‐Arévalo(Instituto Maimónides de Investigación Biomédica de Córdoba), Julia Carrasco‐Valiente(Instituto Maimónides de Investigación Biomédica de Córdoba), Esther Rivero‐Cortés(Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition), Alejandro Ibáñez‐Costa(Instituto de Salud Carlos III), M.J. Requena(Instituto Maimónides de Investigación Biomédica de Córdoba), Justo P. Castaño(Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition), J. Valero-Rosa(Instituto Maimónides de Investigación Biomédica de Córdoba)
Cancer Letters
September 30, 2016
Cited by 38


Related Papers